Instead, the levels of blood lipids molecules, including TG, HDL‐C, Apo A1, Apo B, were changed when compared to those in clinical references, indicating these epileptics might be in a trend of developing dyslipidemia. This evidence concerns the gene APOB and metabolic syndrome.